Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease.Clin Liver Dis. 2019; 23: 39-50
- The relationship between different dimensions of alcohol use and the burden of disease-an update.Addict. 2017; 112: 968-1001
- Advances in the science and treatment of alcohol use disorder.Sci Adv. 2019; 5: eaax4043
- 2010 National and state costs of excessive alcohol consumption.Am J Prev Med. 2015; 49: e73-e79
Organization WH. Global Status Report on Alcohol and Health 2018. 2018. Available at: https://www.who.int/publications/i/item/9789241565639.
- Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III.JAMA Psychiatry. 2015; 72: 757-766
- Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American association for the study of liver diseases.Hepatol. 2020; 71: 306-333
- Alcoholic liver disease: pathogenesis and new therapeutic targets.Gastroenterol. 2011; 141: 1572-1585
- Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.BMJ. 2018; 362: k2817
- Global burden of alcohol use disorders and alcohol liver disease.Biomedicines. 2019; 7https://doi.org/10.3390/biomedicines7040099
- Consequences of perceived stigma among patients with cirrhosis.Dig Dis Sci. 2014; 59: 681-686
- Alcohol use disorders in alcoholic liver disease.Clin Liver Dis. 2019; 23: 55-69
- Primary care validation of a single-question alcohol screening test.J Gen Intern Med. 2009; 24: 783-788
- Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II.Addict. 1993; 88: 791-804
- AUDIT-C as a brief screen for alcohol misuse in primary care.Alcohol Clin Exp Res. 2007; 31: 1208-1217
- Follow-up of alcohol consumption after liver transplantation: interest of an addiction team?.Alcohol Clin Exp Res. 2017; 41: 165-170
- Gender Disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis.Alcohol Clin Exp Res. 2019; 43: 334-341
- Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model.Regul Toxicol Pharmacol. 2018; 94: 163-171
- Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.Alcohol Clin Exp Res. 2014; 38: 1706-1711
- Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis.Transpl Int. 2004; 17: 617-621
- Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease.Alcohol Clin Exp Res. 2001; 25: 1729-1733
- The genetics of alcohol dependence and alcohol-related liver disease.J Hepatol. 2017; 66: 195-211
- Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: a nationwide retrospective cohort study.J Hepatol. 2017; 67: 454-461
- Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.Gastroenterology. 2002; 122: 281-289
- Pathogenesis of alcoholic liver disease.Clin Liver Dis. 2016; 20: 445-456
- Pathophysiology and management of alcoholic liver disease: update 2016.Gut Liver. 2017; 11: 173-188
- Diagnosis and treatment of alcohol-associated liver disease: a review.JAMA. 2021; 326: 165-176
- Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis.Transl Gastroenterol Hepatol. 2020; 5: 19
- Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.J Magn Reson Imaging. 2011; 34: 729-749
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.Hepatology. 2011; 54: 1082-1090
- Current management and future treatment of alcoholic hepatitis.Gastroenterol Hepatol (N Y). 2020; 16: 178-189
- Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.Ann Intern Med. 1989; 110: 685-690
- Current management of alcohol-associated liver disease.Gastroenterol Hepatol (N Y). 2020; 16: 561-570
- Alcoholic hepatitis: a review.Alcohol Alcohol. 2019; 54: 408-416
- The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.Hepatol Jun. 2007; 45: 1348-1354
- A day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis.Am J Gastroenterol. 2017; 112: 306-315
- A new scoring system for prognostic stratification of patients with alcoholic hepatitis.Am J Gastroenterol. 2008; 103: 2747-2756
- MELD accurately predicts mortality in patients with alcoholic hepatitis.Hepatol. 2005; 41: 353-358
- Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function.Am J Gastroenterol. 2008; 103: 1698-1706
- Alcohol-related cirrhosis--early abstinence is a key factor in prognosis, even in the most severe cases.Addiction. 2009; 104: 768-774
- Determinants of long-term outcome in severe alcoholic hepatitis.Aliment Pharmacol Ther. 2013; 38: 584-595
- Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study.Hepatology. 2017; 66: 1464-1473
- Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival.Hepatology. 2017; 66: 1842-1853
- Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American association for the study of liver diseases alcohol-associated liver disease special interest group.Clin Gastroenterol Hepatol. 2021; 19: 2407-2416.e8
- Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.N Engl J Med. 2011; 365: 1781-1789
- Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and Network meta-analysis.Gastroenterology. 2015; 149: 958-970.e12
- The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis.Liver Int. 2015; 35: 1974-1982
- Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids.Gastroenterol Apr. 2016; 150: 903-910.e8
- Associations between zinc deficiency and metabolic abnormalities in patients with chronic liver disease.Nutrients. 2018; 10https://doi.org/10.3390/nu10010088
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice.J Clin Invest. 2012; 122: 3476-3489
- Emerging medical therapies for severe alcoholic hepatitis.Clin Mol Hepatol. 2020; 26: 686-696
- IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.Hepatol. 2022; 27https://doi.org/10.1002/hep.32478
- Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.Alcohol. 2008; 42: 675-682
- Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury.Am J Physiol Gastrointest Liver Physiol. 2012; 303: G32-G41
- Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury.J Nutr Biochem Sep. 2013; 24: 1609-1615
- Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study.Clin Gastroenterol Hepatol. 2017; 15: 600-602
- Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.Hepatology. 2008; 48: 221-229
- Efficacy of granulocyte colony-stimulating factor and N-acetylcysteine therapies in patients with severe alcoholic hepatitis.Clin Gastroenterol Hepatol. 2018; 16: 1650-1656.e2
- An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis.Hepatol. 2020; 72: 441-453
- A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.J Hepatol. 2007; 47: 277-283
- Effects of Metadoxine on cellular status of glutathione and of enzymatic defence system following acute ethanol intoxication in rats.Drugs Exp Clin Res. 1996; 22: 17-24
- Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.Ann Hepatol. 2014; 13: 343-352
- Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery.Liver Transpl. 2000; 6: 769-776
- Evaluation and selection of the patient with alcoholic liver disease for liver transplant.Clin Liver Dis. 2012; 16: 851-863
- Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States.Liver Transpl Surg. 1997; 3: 220-226
- A model to examine the validity of the 6-month abstinence criterion for liver transplantation.Alcohol Clin Exp Res. 1998; 22: 513-517
- Early liver transplantation for severe alcoholic hepatitis.N Engl J Med. 2011; 365: 1790-1800
- Outcomes of early liver transplantation for patients with severe alcoholic hepatitis.Gastroenterology. 2018; 155: 422-430.e1
- DSM-5 criteria for substance use disorders: recommendations and rationale.Am J Psychiatry. 2013; 170: 834-851
Article info
Publication history
Published online: October 17, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
